DiscoverThe Payer Exchange
The Payer Exchange
Claim Ownership

The Payer Exchange

Author: Verpora

Subscribed: 2Played: 3
Share

Description

Unscripted conversations with the people shaping drug pricing, access, and reimbursement around the world.


Hosted by Omar Ali, Head of Payers at Verpora, The Payer Exchange brings you honest, off-the-record discussions with payers working at the frontline of healthcare funding. Each episode features a one-to-one conversation with a payer from a different country—exploring local challenges, emerging trends, and contrasting approaches to some of the biggest questions in market access.


From horizon scanning to contracting, rare disease to real-world evidence, we ask the same core questions—but get different answers every time.


This isn’t a panel. It’s not a pitch. It’s a rare chance to hear what really drives decision-making—direct from those making the decisions.

17 Episodes
Reverse
In the final episode of Season 3, Omar Ali speaks with Ross Margulies of Manatt Health about the policy and legal changes reshaping US pharmaceutical pricing and their consequences far beyond the United States. They discuss Most Favoured Nation (MFN) and international reference pricing, GUARD and GLOBE, the legal durability of current reforms, the move to formal CMS rulemaking, Part B medicines and provider incentives. Ross also explains why manufacturers are already rethinking launch sequenc...
E13: USA - Matt Harman

E13: USA - Matt Harman

2026-09-1649:34

Continuing the US-focused series, Omar Ali speaks with Matt Harman, VP of Clinical Solutions at Employers Health, bringing an employer-sponsored health plan perspective to questions of affordability, access and benefit sustainability. They discuss commercial spillover from Medicare reforms, specialty pipeline risk, medical benefit visibility, biosimilars, GLP-1 affordability and the changing role of Pharmacy Benefit Managers (PBM)s. Matt explains how Employers Health works with self-insured e...
In Episode 12, Omar Ali speaks with Drake Reiter, Director of Pharmacy Operations at Priority Health, about how a regional US health plan is thinking about the next phase of pricing and contracting reform. They discuss Most Favoured Nation (MFN), the Inflation Reduction Act (IRA) and Pharmacy Benefit Manager (PBM) reform, the gradual erosion of rebate-led contracting, commercial spillover from Medicare Most Fair Pricing (MFPs), transparency, formulary leverage and whether a different definiti...
E11: USA - Jill Hanson

E11: USA - Jill Hanson

2026-09-0227:53

Launching Series 3 of The Payer Exchange’s special US focus, Omar Ali speaks with Jill Hanson, VP of Regional Pharmacy at Centene Pharmacy Services, who brings a specialty pharmacy perspective to changes in drug pricing, contracting and medical benefit management, from one of the largest Medicaid managed care organisations in the US. The conversation covers MFN, GUARD and GLOBE, the shift away from rebate maximisation, high-cost therapy forecasting, Part B pricing and site-of-care opti...
What happens when the world’s largest pharmaceutical market fundamentally changes the way it pays for medicines? As US policy evolves around Most Favoured Nation pricing, the Inflation Reduction Act, CMS drug price negotiations and international reference pricing, the consequences could influence launch sequencing, commercial strategy and patient access around the world. Season 3 of The Payer Exchange has a special US focus, bringing together complementary perspectives from specialty pharmacy...
loading
Comments